Clovis Oncology, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €128.16M -9.6% -€227.90M -28.4% -177.8% +0.47 pp -€168.64M -19.9% -131.6% +0.17 pp
    €141.74M +15.0% -€318.09M -7.8% -224.4% +0.56 pp -€210.54M -19.8% -148.5% +0.64 pp
    €123.21M +49.9% -€344.98M +8.8% -280.0% +1.1 pp -€262.41M +0.9% -213.0% +1.0 pp
    €82.18M +71.8% -€317.06M +6.2% -385.8% +2.4 pp -€259.98M +17.5% -316.3% +1.5 pp
    €47.83M +71,067.9% -€298.44M -0.8% -624.0% +4.5K pp -€221.25M -3.4% -462.6% +3.4K pp
    €67.20K +∞% -€300.80M -1.1% -447,611.5% -4.5K pp -€229.10M +6.4% -340,915.4% -3.4K pp
    €0.00 -100.0% -€304.01M +120.5% N/A -€215.41M +117.9% N/A
    €11.74M +∞% -€137.87M +89.3% -1,174.5% -12 pp -€98.88M +60.3% -842.3% -8.4 pp
    €0.00 +NaN% -€72.83M +14.3% N/A -€61.68M +11.3% N/A
    €0.00 +NaN% -€63.74M +33.1% N/A -€55.42M +63.3% N/A
    €0.00 +NaN% -€47.88M +46.9% N/A -€33.93M +18.5% N/A
    €0.00 -€32.59M N/A -€28.64M N/A

    Notifications